Collectively, this pan-cancer analysis reveals the context-dependent roles of coatomer subunits and identifies <i>COPG1</i> as a novel oncogenic driver and potential therapeutic target in HCC, mediating chemoresistance through redox modulation and PI3K-AKT pathway inhibition. The gene discussed is AKT1; the disease is cancer.